ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft failure"

  • 2017 American Transplant Congress

    Systemic Meta-Analysis: Is Early Conversion to mTOR Inhibitors Represent a Suitable Choice in Renal Transplant Recipients?

    K. Jayant,1 I. Reccia,2 J. Walton,1 A. Sharma,3 A. Halawa.1

    1Faculty of Health and Sciences, Institute of Learning and Teaching, University of Liverpool, Liverpool, United Kingdom; 2Department of Hepato-Pancreato-Biliary Surgery (HPB), Hammersmith Hospital, Imperial College, London, United Kingdom; 3Sheffield Teaching Hospitals, Sheffield Teaching Hospitals, Sheffield, United Kingdom

    Aim: This meta-analysis focuses on the current evidence of renal graft functioning and graft survival following early conversion to mTOR inhibitors with or without CNI…
  • 2017 American Transplant Congress

    Impact of Non-Adherence in a Cohort of Kidney Transplant Recipients.

    M. Merino-López,1 C. Flores-Gama.2

    1National Autonomous University of Mexico, Mexico, Mexico; 2Nephrology, National Institute of Cardiology, Mexico, Mexico

    Background: The understanding of the main causes of allograft losts and related factors is a critical in the sucess of kidney transplantation programs.Objective: The aim…
  • 2017 American Transplant Congress

    Protease Inhibitor-Based Regimens Are Associated with Inferior Outcomes in HIV-Infected Kidney Transplant Recipients.

    B. Shelton,1 D. Sawinski,2 R. Reed,1 P. MacLennan,1 S. Mehta,1 J. Locke.1

    1University of Alabama at Birmingham, Birmingham; 2University of Pennsylvania, Philadelphia

    Background: Excellent outcomes have been demonstrated among HIV-infected kidney transplant (KT) recipients when HIV infection is well-controlled. Protease inhibitors (PI) have significant drug-drug interactions with…
  • 2017 American Transplant Congress

    Identifying the Specific Causes and the Determinants of Outcome in Kidney Recipients with Transplant Glomerulopathy: A Multicenter Study.

    O. Aubert,1 S. Higgins,1 P. Campbell,2 C. Loheac,1 D. Viglietti,1 D. Glotz,1 C. Legendre,1 C. Lefaucheur,1 B. Sis,2 J. Duong Van Huyen,1 A. Loupy.1

    1Paris Translational Research Center for Organ Transplantation, Paris, France; 2University of Edmonton, Edmonton, Canada

    BackgroundUnderstanding the specific causes of TG and its long-term consequences at population scale is lacking.MethodsThis study includes all kidney allograft biopsies performed between 2004 and…
  • 2017 American Transplant Congress

    Continuation of Immunosuppression Appears to Protect Against Allosensitization in Patients Listed for a Second Kidney Transplant.

    S. Kuppachi,1 M. Sanders,1 R. Kalil,1 Z. Stewart,2 C. Thomas.1

    1Internal Medicine, University of Iowa, Iowa City, IA; 2Transplant Surgery, University of Iowa, Iowa City, IA

    Purpose: The current standard of practice after allograft loss is to discontinue immunosuppression (IS) to decrease complications related to prolonged exposure. There is a paucity…
  • 2017 American Transplant Congress

    Post-Transplant Graft Function Is Associated with Major Cardiovascular Events in Kidney Transplant Recipients: A Multicenter Cohort Study.

    J. Park,1 Y. Kim,2 S. Yang,3 S. Park,2 S.-K. Park,4 D. Han,5 Y. Kim,2 Y. Kim,5 J. Lee.6

    1Department of Internal Medicine, Dongguk University Ilsan Hospital, Gyeonggi-do, Korea; 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; 3Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea; 4Department of Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea; 5Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea; 6Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea

    Background: Reduced kidney function is an independent risk factor for cardiovascular disease in the general population. However, the association between post-transplantation graft function and subsequent…
  • 2017 American Transplant Congress

    Allograft Crescent Predicts Graft Failure in Recurrent IgA Nephropathy Patients.

    S. Park, H. Cho, M.-Y. Yu, Y. Kim, K. Moon, Y. Kim, H. Lee.

    Seoul National University Hospital, Seoul, Korea

    Background A recent multicenter study demonstrates predictive value of crescents in native IgA nephropathy (IgAN), however it remains unclear whether allograft crescent is associated with…
  • 2017 American Transplant Congress

    Higher Tacrolimus Blood Levels Predict Better Graft Survival in Kidney Recipients with De Novo DSA.

    M.-A. Béland,1 R. Noël,1 I. Côté,1 I. Lapointe,1 E. Wagner,2 J. Riopel,3 E. Latulippe,3 O. Désy,1 S. Béland,1 I. Houde,1 S. De Serres.1

    1Renal Division, CHU de Quebec, Laval University, Quebec City, QC, Canada; 2Immunology and Histocompatibility, CHU de Quebec, Laval University, Quebec City, QC, Canada; 3Pathology, CHU de Quebec, Laval University, Quebec City, QC, Canada

    Background: De novo anti-HLA donor specific antibodies (dnDSA) are associated with poorer outcomes in kidney transplant recipients. Nonetheless, their monitoring post transplant is not widespread,…
  • 2017 American Transplant Congress

    Outcomes of Kidney Transplantation After Primary, Repeat and Kidney After Nonrenal Solid Organ Transplantation: 10 Years UNOS Database Analysis.

    J. Ramirez,1 H. Aghil,1 M. Baz,3 B. Sawaya,1 N. Rajagopalan,2 X. Mei,3 R. Gedaly,3 A. El-Husseini.1

    1Division of Nephrology, University of Kentucky, Lexington, KY; 2Division of Cardiology, University of Kentucky, Lexington, KY; 3Division of Transplant Surgery, University of Kentucky, Lexington, KY

    Introduction: The aim of the study is to evaluate patient and kidney allograft survivals in primary, repeat, and kidney after nonrenal organ transplantation using national…
  • 2017 American Transplant Congress

    Impact of Induction Immunosuppression on the Recurrence of Primary IgA Nephropathy.

    K. Lee, C. Cho, N. Lee, K. Kim, S. Kim, J. Lee, J. Lee, H. Park, J. Park, S. Kim.

    Department of Surgery, Samsung Medical Center, Seoul, Korea

    PurposeIgA nephropathy (IgAN) may recur after kidney transplantation (KT) and potentially jeopardize the survival of the graft. The object of this study was to analyze…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 55
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences